Prospects for pharmacotherapy of schizophrenia

Lancet. 1995 Mar 4;345(8949):557-62. doi: 10.1016/s0140-6736(95)90469-7.
No abstract available

Publication types

  • Review

MeSH terms

  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / pharmacology
  • Antipsychotic Agents / therapeutic use*
  • Basal Ganglia Diseases / chemically induced
  • Clozapine / pharmacology
  • Clozapine / therapeutic use
  • Humans
  • Isoxazoles / pharmacology
  • Isoxazoles / therapeutic use
  • Piperidines / pharmacology
  • Piperidines / therapeutic use
  • Receptors, Dopamine / drug effects
  • Receptors, Dopamine D2 / drug effects
  • Receptors, Serotonin / drug effects
  • Risperidone
  • Schizophrenia / drug therapy*

Substances

  • Antipsychotic Agents
  • Isoxazoles
  • Piperidines
  • Receptors, Dopamine
  • Receptors, Dopamine D2
  • Receptors, Serotonin
  • Clozapine
  • Risperidone